Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|June 23, 2022
Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain MetastasesXiao Luo, Hui Xie, Yadi Yang, et al.
Abdominal Radiology (New York)|April 4, 2022
Discriminating rectal cancer grades using restriction spectrum imagingZhongyan Xiong, Zhijun Geng, Shanshan Lian, et al.
European Radiology|February 23, 2020
A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinomaLin Lu, Deling Wang, Lili Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2022
Tumor response evaluation by combined modalities of chest magnetic resonance imaging and computed tomography in locally advanced non-small cell lung cancer after concurrent chemoradiotherapyDaQuan Wang, Bo Qiu, HaoQiang He, et al.
Eclinicalmedicine|April 17, 2025
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trialFangJie Liu, DaQuan Wang, YuMing Rong, et al.
European Radiology|July 24, 2020
Correction to: A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinomaLin Lu, Deling Wang, Lili Wang, et al.
Abdominal Radiology (New York)|February 19, 2026
Preoperative prediction of preserved renal parenchymal volume via multilevel CT feature fusion: a proof-of-concept studyZhiming Wu, Wenjie Liang, Jiamin Zeng, et al.
Frontiers in Oncology|October 24, 2022
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignanciesFanJun Meng, XinLei Ai, Bin Wang, et al.
Journal for Immunotherapy of Cancer|June 23, 2024
Correlation of K<sup>trans</sup> derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapyDaQuan Wang, SongRan Liu, Jia Fu, et al.
Cancer|December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 studyPengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.
Pageof 3